• जीव्र गाउट | |
acute: तीव्र | |
gout: गठिया थक्का | |
acute gout मीनिंग इन हिंदी
acute gout उदाहरण वाक्य
उदाहरण वाक्य
अधिक: आगे- This has proven useful in the treatment of acute gout flares.
- NSAIDs are often used in treatment of acute gout attacks.
- His cause of death was certified as heart failure brought on by acute gout.
- Without treatment, episodes of acute gout may develop into chronic gout with destruction of joint surfaces, joint deformity and painless tophi.
- Without treatment, episodes of acute gout may develop into chronic gout with destruction of joint surfaces, joint deformity, and painless tophi.
- Its use in acute gout attacks and in dysmenorrhea is well-established because in these indications the duration of treatment is limited to a few days only, therefore serious side effects are not likely to occur.
- Through the Unapproved Drugs Initiative, the FDA sought more rigorous testing of efficacy and safety of colchicine and other unapproved drugs . under the Hatch-Waxman Act, based in part on URL-funded research in 2007, including pharmacokinetic studies and a randomized control trial with 185 patients with acute gout.
- On July 30, 2009 the FDA approved colchicine as a monotherapy for the treatment of three different indications ( familial Mediterranean fever, acute gout flares, and for the prophylaxis of gout flares in exchange for URL Pharma doing 17 new studies and investing $ 100 million into the product, of which $ 45 million went to the FDA for the application fee.
- Urosolvine contains, in the form of effervescent salts, piperazine ( 0.128 grams ) ( increases the solubility of urates ), colchicine ( 0.3 milligrams ) ( brings rapid relief in cases of acute gout attacks ), atropine ( 0.128 milligrams ) ( relieves spasms of the urinary tract ) and sodium citrate ( an alkalinizing agent ).
- In 2009, the FDA approved colchicine as a monotherapy for the treatment of three different indications ( familial Mediterranean fever, acute gout flares, and for the prophylaxis of gout flares ) and gave URL Pharma a three-year marketing exclusivity agreement in exchange for URL Pharma doing 17 new studies and investing $ 100 million into the product ( of which $ 45 million went to the FDA for the application fee ).